It is well established that IFN-γ signalling promotes the expression of PD-L1 in the tumour microenvironment [42,43,44,45], and blocking the PD-1/PD-L1 axis could potentially enhance IFN-mediated inflammatory responses [46]. The gene discussed is CD274; the disease is neoplasm.